Cytokinetics reported $494.94M in Current Assets for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Assets Change
Acadia Pharmaceuticals ACAD:US $ 640.92M 4.81M
Acceleron Pharma XLRN:US $ 696.61M 21.16M
Amgen AMGN:US $ 24380M 5281M
Arca Biopharma ABIO:US $ 68.73M 16.79M
Bayer BAYN:GR 31.94B 506M
Biogen BIIB:US $ 7162.3M 21.4M
Brainstorm Cell Therapeutics BCLI:US $ 27.94M 7.24M
Bristol Myers Squibb BMY:US $ 31443M 2282M
Cytokinetics CYTK:US $ 494.94M 130.71M
Eisai 4523:JP Y 570717M 8210M
Eli Lilly And LLY:US $ 17808.3M 512.8M
Exelixis EXEL:US $ 1662.03M 68.78M
Genocea Biosciences GNCA:US $ 50.61M 12.3M
Geron GERN:US $ 179.36M 22.41M
Halozyme Therapeutics HALO:US $ 1017.3M 17.55M
Intra Cellular Therapies ITCI:US $ 533.24M 68.06M
Ligand Pharmaceuticals LGND:US $ 432.08M 21.18M
Novartis NOVN:VX 26.25B 2.45B
Regeneron Pharmaceuticals REGN:US $ 13775.4M 437.8M